Items where Author is "Schreder, M."
![]() | Up a level |
Article
Knop, S. and Langer, C. and Engelhardt, M. and Muegge, L.-O. and Reichle, A. and Roesler, W. and Bassermann, F. and Hertenstein, B. and Kunitz, A. and Roellig, C. and Ostermann, H. and Schaefer-Eckart, K. and Ringhoffer, M. and Guenther, A. and Junghanss, C. and Biersack, H. and Schreder, M. and Liebert, A. and Held, S. and Einsele, H. and Bargou, R. C. (2017) Lenalidomide, adriamycin, dexamethasone for induction followed by stem-cell transplant in newly diagnosed myeloma. LEUKEMIA, 31 (8). pp. 1816-1819. ISSN 0887-6924, 1476-5551
Other
Knop, S. and Langer, C. and Engelhardt, M. and Stuebig, T. and Schreder, M. and Dechow, T. and Muegge, L. -O. and Bassermann, F. and Schaefer-Eckart, K. and Blau, I. -W. and Wolleschak, D. and Kropff, M. and Reichle, A. and von Metzler, I. and Metzner, B. and Roellig, C. and Hertenstein, B. and Pfreundschuh, M. and Duerk, H. and Biersack, H. and Ostermann, H. and Menzel, H. and Schleicher, J. and Gramatzki, M. and Gerecke, C. and Mueller, M. and Brueggemann, M. and Held, S. and Einsele, H. (2017) Lenalidomide, adriamycin and dexamethasone (RAD) versus bortezomib, lenalidomide and dexamethasone (VRD) as induction regimens in newly diagnosed multiple myeloma - first results from the DSMM XIV study. KARGER, BASEL.
Schreder, M. and Liebisch, P. and Hebart, H. and Holler, E. and Engelhardt, M. and Metzner, B. and Peest, D. and Aulitzky, W. and Straka, C. and Fischer, T. and Sezer, O. and Hentrich, M. and Ostermann, H. and Peschel, C. and Hess, G. and Hertenstein, B. and Wolf, H. -H and Jung, W. and Frickhofen, N. and Maschmeyer, G. and Langer, C. and Meisner, C. and Kanz, L. and Einsele, H. and Knop, S. (2016) Randomized comparison of pegylated IFN-a2b versus IFN-a2b maintenance following tandem autologous transplant in multiple myeloma. KARGER, BASEL.

